DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 151 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $897,028 | -13.5% | 70,521 | -4.3% | 0.02% | -5.0% |
Q2 2023 | $1,037,485 | +17.7% | 73,685 | +29.2% | 0.02% | +17.6% |
Q1 2023 | $881,361 | -5.7% | 57,046 | +0.0% | 0.02% | -5.6% |
Q4 2022 | $934,526 | +74.4% | 57,018 | +96.9% | 0.02% | +63.6% |
Q3 2022 | $536,000 | +3.9% | 28,959 | -26.1% | 0.01% | +22.2% |
Q2 2022 | $516,000 | +8.9% | 39,168 | -23.3% | 0.01% | +28.6% |
Q1 2022 | $474,000 | +35.8% | 51,060 | +43.2% | 0.01% | +75.0% |
Q4 2021 | $349,000 | +73.6% | 35,656 | +503.6% | 0.00% | +33.3% |
Q3 2021 | $201,000 | -7.4% | 5,907 | +0.1% | 0.00% | +50.0% |
Q2 2021 | $217,000 | – | 5,904 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |